Morgan Stanley’s Adeptus Health Inc ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,042,796
Closed -$1.88M 6795
2017
Q1
$1.88M Sell
1,042,796
-110,583
-10% -$621K ﹤0.01% 3869
2016
Q4
$8.81M Buy
1,153,379
+20,551
+2% +$378K ﹤0.01% 2392
2016
Q3
$48.8M Buy
1,132,828
+1,072,161
+1,767% +$48.4M 0.02% 870
2016
Q2
$3.13M Buy
60,667
+48,332
+392% +$2.9M ﹤0.01% 3041
2016
Q1
$686K Buy
12,335
+7,642
+163% +$395K ﹤0.01% 4217
2015
Q4
$255K Sell
4,693
-20,568
-81% -$1.31M ﹤0.01% 4957
2015
Q3
$2.04M Sell
25,261
-11,458
-31% -$1.18M ﹤0.01% 3488
2015
Q2
$3.49M Buy
36,719
+25,623
+231% +$1.76M ﹤0.01% 3127
2015
Q1
$558K Sell
11,096
-11,829
-52% -$468K ﹤0.01% 4581
2014
Q4
$857K Sell
22,925
-26,576
-54% -$837K ﹤0.01% 4277
2014
Q3
$1.23M Buy
+49,501
New +$1.29M ﹤0.01% 3863

Other funds holding ADPT

Morgan Stanley's ADPT Position: Q2 2017 in Review

Morgan Stanley sold out of Adeptus Health Inc (ADPT) in Q2 2017, closing a stake of 1,042,796 shares — an estimated $1.88M sold.

Morgan Stanley first reported a position in ADPT in Q3 2014 and held it in 11 quarters. The position peaked at $48.8M in Q3 2016. 9 funds tracked by Wall St. Rank hold ADPT as of Q2 2017.

  • Morgan Stanley reported no remaining Adeptus Health Inc position as of Q2 2017 after selling out during the quarter.
  • Morgan Stanley sold 1,042,796 Adeptus Health Inc shares in Q2 2017, an estimated $1.88M.
  • Morgan Stanley first reported a position in Adeptus Health Inc in Q3 2014 and held it in 11 quarters.
  • Morgan Stanley's Adeptus Health Inc position peaked at $48.8M in Q3 2016.
  • 9 funds tracked by Wall St. Rank held Adeptus Health Inc as of Q2 2017.

Based on Morgan Stanley's 13F filing for Q2 2017, filed 11 Aug 2017.